133 related articles for article (PubMed ID: 7744765)
1. Properties of an N-terminal proteolytic fragment of apolipoprotein AI in solution and in reconstituted high density lipoproteins.
Ji Y; Jonas A
J Biol Chem; 1995 May; 270(19):11290-7. PubMed ID: 7744765
[TBL] [Abstract][Full Text] [Related]
2. Role of individual amino acids of apolipoprotein A-I in the activation of lecithin:cholesterol acyltransferase and in HDL rearrangements.
Cho KH; Durbin DM; Jonas A
J Lipid Res; 2001 Mar; 42(3):379-89. PubMed ID: 11254750
[TBL] [Abstract][Full Text] [Related]
3. Conformation of apolipoprotein AI in reconstituted lipoprotein particles and particle-membrane interaction: effect of cholesterol.
Tricerri A; Córsico B; Toledo JD; Garda HA; Brenner RR
Biochim Biophys Acta; 1998 Mar; 1391(1):67-78. PubMed ID: 9518555
[TBL] [Abstract][Full Text] [Related]
4. Structural and functional properties of reconstituted high density lipoprotein discs prepared with six apolipoprotein A-I variants.
Jonas A; von Eckardstein A; Kézdy KE; Steinmetz A; Assmann G
J Lipid Res; 1991 Jan; 32(1):97-106. PubMed ID: 1901346
[TBL] [Abstract][Full Text] [Related]
5. Structural and functional properties of V156K and A158E mutants of apolipoprotein A-I in the lipid-free and lipid-bound states.
Han JM; Jeong TS; Lee WS; Choi I; Cho KH
J Lipid Res; 2005 Mar; 46(3):589-96. PubMed ID: 15716588
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein AI tertiary structures determine stability and phospholipid-binding activity of discoidal high-density lipoprotein particles of different sizes.
Chen B; Ren X; Neville T; Jerome WG; Hoyt DW; Sparks D; Ren G; Wang J
Protein Sci; 2009 May; 18(5):921-35. PubMed ID: 19384992
[TBL] [Abstract][Full Text] [Related]
7. Branched synthetic constructs that mimic the physico-chemical properties of apolipoprotein AI in reconstituted high-density lipoproteins.
Demoor L; Boutillon C; Fievet C; Vanloo B; Baert J; Rosseneu M; Fruchart JC; Tartar A
Eur J Biochem; 1996 Jul; 239(1):74-84. PubMed ID: 8706721
[TBL] [Abstract][Full Text] [Related]
8. Cholesterol mobilization by free and lipid-bound apoAI(Milano) and apoAI(Milano)-apoAII heterodimers.
Wang WQ; Moses AS; Francis GA
Biochemistry; 2001 Mar; 40(12):3666-73. PubMed ID: 11297434
[TBL] [Abstract][Full Text] [Related]
9. Pegylation of high-density lipoprotein decreases plasma clearance and enhances antiatherogenic activity.
Murphy AJ; Funt S; Gorman D; Tall AR; Wang N
Circ Res; 2013 Jun; 113(1):e1-e9. PubMed ID: 23613182
[TBL] [Abstract][Full Text] [Related]
10. Cuban Sugar Cane Wax Alcohol Exhibited Enhanced Antioxidant, Anti-Glycation and Anti-Inflammatory Activity in Reconstituted High-Density Lipoprotein (rHDL) with Improved Structural and Functional Correlations: Comparison of Various Policosanols.
Cho KH; Baek SH; Nam HS; Kim JE; Kang DJ; Na H; Zee S
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834595
[TBL] [Abstract][Full Text] [Related]
11. The carboxyl-terminal hydrophobic residues of apolipoprotein A-I affect its rate of phospholipid binding and its association with high density lipoprotein.
Laccotripe M; Makrides SC; Jonas A; Zannis VI
J Biol Chem; 1997 Jul; 272(28):17511-22. PubMed ID: 9211897
[TBL] [Abstract][Full Text] [Related]
12. Branched synthetic peptide constructs mimic cellular binding and efflux of apolipoprotein AI in reconstituted high density lipoproteins.
Nion S; Demoor L; Boutillon C; Luchoomun J; Vanloo B; Fievet C; Castro G; Rosseneu M; Fruchart JC; Tartar A; Clavey V
Atherosclerosis; 1998 Dec; 141(2):227-35. PubMed ID: 9862171
[TBL] [Abstract][Full Text] [Related]
13. Structural and functional properties of full-length and truncated human proapolipoprotein AI expressed in escherichia coli.
Pyle LE; Sawyer WH; Fujiwara Y; Mitchell A; Fidge NH
Biochemistry; 1996 Sep; 35(37):12046-52. PubMed ID: 8810909
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein A-I structure and lipid properties in homogeneous, reconstituted spherical and discoidal high density lipoproteins.
Jonas A; Wald JH; Toohill KL; Krul ES; Kézdy KE
J Biol Chem; 1990 Dec; 265(36):22123-9. PubMed ID: 2125044
[TBL] [Abstract][Full Text] [Related]
15. The Arg123-Tyr166 central domain of human ApoAI is critical for lecithin:cholesterol acyltransferase-induced hyperalphalipoproteinemia and HDL remodeling in transgenic mice.
Holvoet P; De Geest B; Van Linthout S; Lox M; Danloy S; Raes K; Collen D
Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):459-66. PubMed ID: 10669644
[TBL] [Abstract][Full Text] [Related]
16. The role of apolipoprotein AI domains in lipid binding.
Davidson WS; Hazlett T; Mantulin WW; Jonas A
Proc Natl Acad Sci U S A; 1996 Nov; 93(24):13605-10. PubMed ID: 8942981
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein A-I configuration and cell cholesterol efflux activity of discoidal lipoproteins depend on the reconstitution process.
Cuellar LÁ; Prieto ED; Cabaleiro LV; Garda HA
Biochim Biophys Acta; 2014 Jan; 1841(1):180-9. PubMed ID: 24201377
[TBL] [Abstract][Full Text] [Related]
18. The impact of glycation on apolipoprotein A-I structure and its ability to activate lecithin:cholesterol acyltransferase.
Nobecourt E; Davies MJ; Brown BE; Curtiss LK; Bonnet DJ; Charlton F; Januszewski AS; Jenkins AJ; Barter PJ; Rye KA
Diabetologia; 2007 Mar; 50(3):643-53. PubMed ID: 17216278
[TBL] [Abstract][Full Text] [Related]
19. Swapping the N- and C-terminal domains of human apolipoprotein E3 and AI reveals insights into their structure/activity relationship.
Lek MT; Cruz S; Ibe NU; Beck WHJ; Bielicki JK; Weers PMM; Narayanaswami V
PLoS One; 2017; 12(6):e0178346. PubMed ID: 28644829
[TBL] [Abstract][Full Text] [Related]
20. Phospholipid binding and lecithin-cholesterol acyltransferase activation properties of apolipoprotein A-I mutants.
Holvoet P; Zhao Z; Vanloo B; Vos R; Deridder E; Dhoest A; Taveirne J; Brouwers E; Demarsin E; Engelborghs Y
Biochemistry; 1995 Oct; 34(41):13334-42. PubMed ID: 7577918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
